Showing posts with label Marketing Pharmaceuticals. Show all posts
Showing posts with label Marketing Pharmaceuticals. Show all posts

Monday, April 1, 2013

Webinar: Preparing for the Physician Payment Sunshine Implementation: Research, Marketing & Education ~ Apr 29


Newly Released Webinar:



All transfers of value to covered recipients must be tracked by covered manufacturers starting August 1. This 90-minute webinar will provide a high-level overview of the basic requirements of the final rule for implementing the Physicians Payment Sunshine Act, before turning to many of the gray areas where manufacturers are struggling to understand what they need to track and report. This webinar will focus on the requirements for research-related activities, indirect payments, and the determination of value for many educational efforts. Industry experts will help you go beyond a cursory understanding of the rule to help their organizations determine how they will ensure compliance and avoid the costly fines.

Monday, February 4, 2013

Latest in Pharmaceutical Marketing, January 2013

Insider Update

Marketing PharmaceuticalsLatest in Pharmaceutical Marketing

It’s not getting any easier to comply with all the regulatory and legal requirements that apply to marketing pharmaceuticals and medical devices. Wayne L. Pines, President, Regulatory Services and Healthcare at APCO Worldwide, Inc., highlights key recent FDA enforcement actions to be discussed at the Marketing Pharmaceuticals Workshop next month: “The recent letters that OPDP issued regarding press materials are certain to be of great interest. In particular, the letter that dealt with a ‘pitch’ letter was very interesting and should engender questions.”
Read full issue.